Skip to main content
. 2016 Nov 29;107(11):1660–1666. doi: 10.1111/cas.13068

Figure 3.

Figure 3

Mutation profiles and clinicopathologic characteristics for 42 mutation‐positive patients with non‐small cell lung carcinoma with a pathological stage of IIA–IIIA. Black and red boxes indicate mutations detected in tumor samples alone or in both tumor and serum samples, respectively. cfDNA, cell‐free DNA; MTD, maximum tumor diameter evaluated by diagnostic imaging; TV; tumor volume calculated during pathological examination.